99 related articles for article (PubMed ID: 6097615)
1. [Clinical evaluation of a pancreatic oncofetal antigen (POA) in carcinoma of the pancreas].
Hishinuma S; Takami H; Matsui J; Uematsu S; Baba H; Ogata Y; Abe O; Miyoshi K; Ishii T; Yamamori S
Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1432-7. PubMed ID: 6097615
[No Abstract] [Full Text] [Related]
2. [Clinical evaluation of enzyme immunoassay for a pancreatic oncofetal antigen (POA)].
Hishinuma S; Takami H; Shintoku J; Matsui J; Uematsu S; Baba H; Ogata Y; Abe O; Ishii T; Miyoshi K
Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2217-24. PubMed ID: 6398349
[No Abstract] [Full Text] [Related]
3. [Studies on a pancreatic oncofetal antigen (POA) in patients with pancreatic cancer].
Hishnuma S
Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1449-60. PubMed ID: 3785134
[TBL] [Abstract][Full Text] [Related]
4. [Pancreatic oncofetal antigen (POA) and carcinoma of the pancreas].
Homma T; Oguchi H; Kawa S; Nagata A; Furuta S
Gan No Rinsho; 1984 May; 30(6 Suppl):558-62. PubMed ID: 6205174
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic usefulness of serum levels of pancreatic oncofetal antigen (POA) and CA 19-9 in pancreatic cancers: monitoring of postoperative recurrences].
Takami H; Hishinuma S; Shintoku J; Ogata Y; Abe O
Gan No Rinsho; 1985 May; 31(6 Suppl):631-7. PubMed ID: 3861883
[TBL] [Abstract][Full Text] [Related]
6. [Biochemical markers in the neoplasms of the liver, biliary tract and pancreas].
Higashino K; Sumikawa K
Nihon Rinsho; 1982; 40(1):43-50. PubMed ID: 6177881
[No Abstract] [Full Text] [Related]
7. [Pancreatic oncofetal antigen (POA)].
Mugitani H; Furue H; Kako M; Hirota F; Fuse K; Takahashi T; Sakamoto K; Yamada K; Suminaga M; Ezaki M; Judo R
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1737-43. PubMed ID: 6882002
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of pancreatic oncofetal antigen (POA) in the diagnosis of pancreatic cancer].
Nishida K
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):601-8. PubMed ID: 6349542
[TBL] [Abstract][Full Text] [Related]
9. [Pancreatic oncofetal antigen (POA)--its characterization and the result of enzyme immunoassay].
Homma T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):617-22. PubMed ID: 6349543
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of pancreatic cancer by pancreatic oncofetal antigen (poa) in pure pancreatic juice.
Nishida K; Kondo M; Jessen K; Classen M
Hepatogastroenterology; 1981 Apr; 28(2):102-5. PubMed ID: 7216142
[TBL] [Abstract][Full Text] [Related]
11. Enzyme immunoassay of pancreatic oncofetal antigen (POA) as a marker of pancreatic cancer.
Nishida K; Sugiura M; Yoshikawa T; Kondo M
Gut; 1985 May; 26(5):450-5. PubMed ID: 3888788
[TBL] [Abstract][Full Text] [Related]
12. Oncofetal antigen-I: distribution in human tumors.
Rees WV; Irie RF; Morton DL
J Natl Cancer Inst; 1981 Sep; 67(3):557-62. PubMed ID: 6268878
[TBL] [Abstract][Full Text] [Related]
13. A pancreatic oncofetal antigen (POA): its characterization and application for enzyme immunoassay.
Oguchi H; Homma T; Kawa S; Nagata A; Furuta S; Fukui H
Cancer Detect Prev; 1984; 7(1):51-8. PubMed ID: 6367984
[TBL] [Abstract][Full Text] [Related]
14. [Immunological markers in the detection of neoplasms of the liver, biliary tract and pancreas].
Matsuno S; Kobari M; Kodera T; Sato T
Nihon Rinsho; 1982; 40(1):51-7. PubMed ID: 6177882
[No Abstract] [Full Text] [Related]
15. Pancreatic oncofetal antigen in the detection of experimental cancer of the pancreas.
Johnson FE; Laregina MC; Gelder FB
Tumour Biol; 1985; 6(1):37-40. PubMed ID: 4023561
[TBL] [Abstract][Full Text] [Related]
16. Purification, partial characterization, and clinical evaluation of a pancreatic oncofetal antigen.
Gelder FB; Reese CJ; Moossa AR; Hall T; Hunter R
Cancer Res; 1978 Feb; 38(2):313-24. PubMed ID: 202385
[No Abstract] [Full Text] [Related]
17. [The existence of alpha 1-fetoprotein apart from hepatoma].
Andrieu J; Breart G; Rodier B; Robert PE
Presse Med (1893); 1971; 79(36):1595-6. PubMed ID: 4328551
[No Abstract] [Full Text] [Related]
18. Pancreatic oncofetal antigen and carbohydrate antigen 19-9 in sera of patients with cancer of the pancreas.
Shahangian S; Fritsche HA; Hughes JI; Gelder FB
Clin Chem; 1989 Mar; 35(3):405-8. PubMed ID: 2537687
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H
Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964
[TBL] [Abstract][Full Text] [Related]
20. [Antigens associated with cancer of the pancreas].
Burtin P
Bull Cancer; 1990; 77(1):69-73. PubMed ID: 2317577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
